UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer

Clinical cancer research, 2003-05, Vol.9 (5), p.1639-1647

2003

Volltextzugriff (PDF)

A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake

Clinical cancer research, 2005-07, Vol.11 (13), p.4810-4817

2005

Volltextzugriff (PDF)

Phase I Study of Anticolon Cancer Humanized Antibody A33

Clinical cancer research, 2003-04, Vol.9 (4), p.1338-1346

2003

Volltextzugriff (PDF)

The Rabbit Antibody Repertoire as a Novel Source for the Generation of Therapeutic Human Antibodies

The Journal of biological chemistry, 2000-05, Vol.275 (18), p.13668-13676

2000

Volltextzugriff (PDF)

Abstract 4880: Anti-membrane IgM monoclonal antibody, WBMP-4, induces apoptosis in B-cell malignancies by modulation of kinase expression and phosphorylation

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.4880-4880

2023

Volltextzugriff (PDF)

Abstract 4682: Membrane protein expression and activity following inhibition of B-cell receptor-initiated signaling by WBMP-4, a therapeutic antibody for leukemia/lymphoma

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.4682-4682

2024

Volltextzugriff (PDF)

Abstract PO020: Anti-membrane-IgM monoclonal antibody, mAb4, inhibits the BCRC, modulating downstream signaling pathways

Cancer immunology research, 2021-02, Vol.9 (2_Supplement), p.PO020-PO020

2021

Volltextzugriff (PDF)

Abstract P40: Therapeutic anti-B-cell Receptor antibody, WBMP-4, modulates malignant B-cell signaling and induces apoptosis

Blood cancer discovery, 2024-03, Vol.5 (2_Supplement), p.P40-P40

2024

Volltextzugriff (PDF)

Abstract PO-59: Anti-membrane IgM monoclonal antibody, mAb4, is a novel, next-generation BTK inhibitor mediating B-cell leukemia and lymphoma cell death

Blood cancer discovery, 2020-11, Vol.1 (3_Supplement), p.PO-59-PO-59

2020

Volltextzugriff (PDF)

Preliminary Report of a Phase I Study of Combination Chemotherapy and Humanized A33 Antibody Immunotherapy in Patients with Advanced Colorectal Cancer

Clinical cancer research, 2003-04, Vol.9 (4), p.1347-1353

2003

Volltextzugriff (PDF)

The Human A33 Antigen is a Transmembrane Glycoprotein and a Novel Member of the Immunoglobulin Superfamily

Proceedings of the National Academy of Sciences - PNAS, 1997-01, Vol.94 (2), p.469-474

1997

Volltextzugriff (PDF)

Abstract 3641: Antibody targeting the IgM B-cell receptor (mBCR) induces growth inhibition and apoptosis

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3641-3641

2014

Volltextzugriff (PDF)

Antibody-mediated modulation of the IgM B-cell receptor (BCR) expression and signaling

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.3050-3050

2014

Volltextzugriff (PDF)

Specificity and biologic activities of novel anti-membrane IgM antibodies

Oncotarget, 2016-11, Vol.7 (46), p.74701-74723

2016

Volltextzugriff (PDF)

Serological and immunochemical analysis of Lewis Y (Ley) blood group antigen expression in epithelial ovarian cancer

International journal of cancer, 1996-02, Vol.65 (4), p.406-412

1996

Volltextzugriff (PDF)

Hematologic toxicity in radioimmunotherapy: dose-response relationships for I-131 labeled antibody therapy

Cancer biotherapy & radiopharmaceuticals, 2002-08, Vol.17 (4), p.435-443

2002

Volltextzugriff (PDF)

Cancer-related serological recognition of human colon cancer: Identification of potential diagnostic and immunotherapeutic targets

Cancer research (Chicago, Ill.), 2002-07, Vol.62 (14), p.4041-4047

2002

Volltextzugriff (PDF)

Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33

Cancer research (Chicago, Ill.), 2001-09, Vol.61 (18), p.6851-6859

2001

Volltextzugriff (PDF)

Characterization of Posttranslational Modifications of Human A33 Antigen, a Novel Palmitoylated Surface Glycoprotein of Human Gastrointestinal Epithelium

Biochemical and biophysical research communications, 1997-07, Vol.236 (3), p.682-686

1997

Volltextzugriff (PDF)

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma

Clinical cancer research, 1998-11, Vol.4 (11), p.2729-2739

1998

Volltextzugriff (PDF)

Antibody-based immunological therapies

Current opinion in immunology, 1997-10, Vol.9 (5), p.717-722

1997

Volltextzugriff (PDF)

Phase I Clinical Trial with Fractionated Radioimmunotherapy Using ^sup 131^I-Labeled Chimeric G250 in Metastatic Renal Cancer

The Journal of nuclear medicine (1978), 2004-08, Vol.45 (8), p.1412

2004

Volltextzugriff (PDF)

Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts

Journal of clinical oncology, 1994-06, Vol.12 (6), p.1193-1203

1994

Volltextzugriff (PDF)

Mucin production by colon cancer cells cultured in serum‐free medium

International journal of cancer, 1991-11, Vol.49 (5), p.787-795

1991

Volltextzugriff (PDF)

Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer

Journal of clinical oncology, 1994-08, Vol.12 (8), p.1561-1571

1994

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(63)

Sprache

Englisch
(63)

Erscheinungsjahr

n.n

Thema

Humans
(40)
Science & Technology
(39)
Life Sciences & Biomedicine
(38)
Biological And Medical Sciences
(34)
Medical Sciences
(31)
Animals
(26)
Female
(23)
Mice
(23)
Oncology
(23)
Pharmacology. Drug Treatments
(16)
Tumors
(14)
Antigens, Neoplasm - Immunology
(13)
Antineoplastic Agents
(13)
Aged
(12)
Antibodies, Monoclonal - Immunology
(12)
Male
(12)
Middle Aged
(12)
Membrane Glycoproteins - Immunology
(11)
Adult
(10)
Antibodies, Monoclonal - Therapeutic Use
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer

A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake

Phase I Study of Anticolon Cancer Humanized Antibody A33

The Rabbit Antibody Repertoire as a Novel Source for the Generation of Therapeutic Human Antibodies

Abstract 4880: Anti-membrane IgM monoclonal antibody, WBMP-4, induces apoptosis in B-cell malignancies by modulation of kinase expression and phosphorylation

Abstract 4682: Membrane protein expression and activity following inhibition of B-cell receptor-initiated signaling by WBMP-4, a therapeutic antibody for leukemia/lymphoma

Abstract PO020: Anti-membrane-IgM monoclonal antibody, mAb4, inhibits the BCRC, modulating downstream signaling pathways

Abstract P40: Therapeutic anti-B-cell Receptor antibody, WBMP-4, modulates malignant B-cell signaling and induces apoptosis

Abstract PO-59: Anti-membrane IgM monoclonal antibody, mAb4, is a novel, next-generation BTK inhibitor mediating B-cell leukemia and lymphoma cell death

Preliminary Report of a Phase I Study of Combination Chemotherapy and Humanized A33 Antibody Immunotherapy in Patients with Advanced Colorectal Cancer

The Human A33 Antigen is a Transmembrane Glycoprotein and a Novel Member of the Immunoglobulin Superfamily

Abstract 3641: Antibody targeting the IgM B-cell receptor (mBCR) induces growth inhibition and apoptosis

Antibody-mediated modulation of the IgM B-cell receptor (BCR) expression and signaling

Specificity and biologic activities of novel anti-membrane IgM antibodies

Serological and immunochemical analysis of Lewis Y (Ley) blood group antigen expression in epithelial ovarian cancer

Hematologic toxicity in radioimmunotherapy: dose-response relationships for I-131 labeled antibody therapy

Cancer-related serological recognition of human colon cancer: Identification of potential diagnostic and immunotherapeutic targets

Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33

Characterization of Posttranslational Modifications of Human A33 Antigen, a Novel Palmitoylated Surface Glycoprotein of Human Gastrointestinal Epithelium

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma

Antibody-based immunological therapies

Phase I Clinical Trial with Fractionated Radioimmunotherapy Using ^sup 131^I-Labeled Chimeric G250 in Metastatic Renal Cancer

Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts

Mucin production by colon cancer cells cultured in serum‐free medium

Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer

Suchergebnisse filtern